Press release
Endoscopic Retrograde Cholangiopancreatography Market Share, Growth and Forecast Report, 2030
In 2021, the endoscopic retrograde cholangiopancreatography market valued at $1,270.9 million, and it is expected to grow at a rate of 8.1% from 2021 to 2030, to hit the $2,557.7 million value by 2030. It is attributed to the growing prevalence of pancreatic disorders in the geriatric population and the increased adoption of minimally invasive procedures. The rise in medical reimbursements is also driving the market. For example, the average cost of an endoscopy procedure is more than $3,000 in the U.S., but due to health insurance, there can be a reduction of $1,500 in the cost.The most-significant revenue generator in the endoscopic retrograde cholangiopancreatography market is endotherapy devices, holding 40% market share. It is ascribed to the growing prevalence of pancreatic disorders such as pancreatitis, gallbladder stones, pancreatic cancer and choledocholithiasis, resulting in rising demand for ERCP devices. According to American Health Organization, the number of people with pancreatic cancer is expected to rise to over 60,000 in 2022 in the U.S., with an estimated forecast of 50,000 deaths from it.
Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/endoscopic-retrograde-cholangiopancreatography-ercp-market/report-sample
Under the application segment, the biliary sphincterotomy captured the largest revenue share, amounting to 45% of the endoscopic retrograde cholangiopancreatography market. It is attributed to the massive usage of the ERCP devices in pancreatic disorder treatment procedures such as common bile duct stones, stent placement, bile obstruction and tissue sampling. On average, 10 out of 100,000 men and women are expected to suffer from intrahepatic bile duct cancer in the U.S., which signifies the increased demand for ERCP devices in the region.
Under the end-user segment, hospitals and clinics contribute significantly to the endoscopic retrograde cholangiopancreatography market. It is attributed to the rise in hospitals with trained and certified endoscopy professionals such as surgeons and gastroenterologists, resulting in the mass interventions of endoscopic diagnosis performed in these facilities. The hospitals and clinics also offer surgical care, including diagnostic and preventive procedures, leading to the proliferation of the market.
North America contributed $471.4 million in revenue to the endoscopic retrograde cholangiopancreatography market last year, attributed to the growing prevalence of pancreatic cancer and the increase in number of deaths caused due to it in the region. Around 3% of deaths are caused due to pancreatic cancer every year in the U.S. The rise in alcohol consumption is also the leading cause of several pancreatic diseases such as PanNET and pancreatic adenocarcinoma.
Browse full report at: https://www.psmarketresearch.com/market-analysis/endoscopic-retrograde-cholangiopancreatography-ercp-market
APAC is expected to witness the fastest growth in the endoscopic retrograde cholangiopancreatography market. It is attributed to the growing prevalence of pancreatic cancer and GERD, and increased patient awareness of ERCP devices. The government initiatives to raise awareness toward pancreatic diseases such as bile duct cancer, pancreatic conditions and other complications are also driving the market. China and Japan collectively hold the 60% share of the APAC market. Around 3,00,000 deaths are reported due to GI-related cancers in China, according to the country's government organization data.
Therefore, the growing prevalence of pancreatic diseases and increased death rate due to pancreatic cancer drive the demand for ERCP devices, resulting in a market boom.
Browse more reports:
Capsule Endoscopes Market - https://www.psmarketresearch.com/market-analysis/capsule-endoscopes-market
U.S. Endoscope Repair Market - https://www.psmarketresearch.com/market-analysis/endoscope-repair-market-us
Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com
About P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endoscopic Retrograde Cholangiopancreatography Market Share, Growth and Forecast Report, 2030 here
News-ID: 2928380 • Views: …
More Releases from P&S Intelligence

Modular Automation Market Poised for Robust Growth Amid Industry 4.0 Transformat …
According to the latest market research study published by P&S Intelligence, the global modular automation market is on an impressive growth trajectory, expected to generate USD 6.3 billion in 2024 and expand at a CAGR of 8.7% to reach USD 12.1 billion by 2032. This surge is driven by rising demand for flexible, cost-efficient manufacturing solutions and the accelerating integration of Industry 4.0 technologies.
As manufacturing landscapes evolve with rapid changes…

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…

Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…

Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
More Releases for ERCP
North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
Introduction
Biliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions.
Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging…
EU5 ERCP and PTC Devices Market to Reach USD 1.5 Billion by 2034
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) are essential diagnostic and therapeutic procedures used to treat conditions affecting the biliary and pancreatic ducts, such as gallstones, tumors, strictures, and obstructions. ERCP is a non-surgical procedure that combines endoscopy and fluoroscopy to evaluate the pancreatic and bile ducts, while PTC is used in cases where ERCP is not feasible, allowing direct visualization of the bile ducts via a needle…
ERCP Device Market Size And Global Industry Forecast 2034
"The Endoscopic Retrograde Cholangiopancreatography (ERCP) device market is currently valued at approximately $1.2 billion in 2024. The market is projected to grow significantly, reaching an estimated $2.4 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled "ERCP Device Market". This report covers the global ERCP Device market sales, sales volume, price,…
Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by …
North America accounted for the largest share of the ERCP market. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.
According to the new market research report "Endoscopic Retrograde Cholangiopancreatography/ERCP Market [https://www.marketsandmarkets.com/Market-Reports/endoscopic-retrograde-cholangiopancreatography-ercp-market-170242954.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket] by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy),…
ERCP Catheter Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growt …
ERCP Catheter Market
The global ERCP Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for ERCP Catheter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ERCP Catheter is…
Asia-Pacific ERCP Devices Market: Navigating Growth and Innovation
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a…